Table 3 Effect of pulmonary rehabilitation in patients with COPD
From: Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?
| Â | Start of rehabilitation | End of rehabilitation | p value |
|---|---|---|---|
Aortic PWV (m/s) | 9.8 (3.0) | 9.3 (2.7) | <0.05 |
Brachial PWV (m/s) | 9.0 (1.7) | 8.9 (1.6) | 0.535 |
AIx (%) | 33.9 (5.3) | 33.6 (8.8) | 0.833 |
Peripheral SBP (mmHg) | 138 (20) | 128 (24) | <0.01 |
Peripheral DBP (mmHg) | 83 (9) | 78 (12) | <0.01 |
Peripheral PP (mmHg) | 55 (15) | 49 (19) | <0.05 |
Peripheral MAP (mmHg) | 101 (12) | 95 (14) | <0.001 |
Central SBP (mmHg) | 126 (21) | 120 (23) | <0.05 |
Central DBP (mmHg) | 83 (12) | 79 (12) | <0.05 |
Central PP (mmHg) | 43 (14) | 41 (18) | 0.471 |
Central MAP (mmHg) | 103 (14) | 95 (14) | <0.001 |
Heart Rate (bpm) | 76 (12) | 76 (14) | 0.933 |
Fasting Glucose (mmol/L) | 5.0 (0.7) | 4.8 (0.8) | 0.079 |
Total Fasting Cholesterol (mmol/L) | 5.6 (1.2) | 5.4 (1.1) | <0.05 |
LDL (mmol/L) | 3.4 (1.1) | 3.3 (1.2) | 0.389 |
HDL (mmol/L) | 1.7 (0.5) | 1.6 (0.4) | 0.050 |
ISWT (m) | 190 (70) | 274 (76) | <0.001 |
SGRQ Total Score | 56.5 (13.9) | 44.9 (16.1) | <0.001 |